These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 24971336)

  • 21. Polymorphisms of XRCC1 gene and risk of gastric cardiac adenocarcinoma.
    Yan L; Yanan D; Donglan S; Na W; Rongmiao Z; Zhifeng C
    Dis Esophagus; 2009; 22(5):396-401. PubMed ID: 19673050
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of X-ray repair cross complementing group 1 Arg399Gln polymorphisms with the risk of squamous cell carcinoma of the head and neck: evidence from an updated meta-analysis.
    Wang Y; Chu X; Meng X; Zou F
    PLoS One; 2013; 8(10):e77898. PubMed ID: 24205020
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Associations between XRCC1 Gene Polymorphisms and Coronary Artery Disease: A Meta-Analysis.
    Ma WQ; Han XQ; Wang X; Wang Y; Zhu Y; Liu NF
    PLoS One; 2016; 11(11):e0166961. PubMed ID: 27870881
    [TBL] [Abstract][Full Text] [Related]  

  • 24. XRCC1 gene polymorphisms and glioma risk in Chinese population: a meta-analysis.
    He LW; Shi R; Jiang L; Zeng Y; Ma WL; Zhou JY
    PLoS One; 2014; 9(11):e111981. PubMed ID: 25375625
    [TBL] [Abstract][Full Text] [Related]  

  • 25. XRCC1 polymorphisms and risk of papillary thyroid carcinoma in a Korean sample.
    Ryu RA; Tae K; Min HJ; Jeong JH; Cho SH; Lee SH; Ahn YH
    J Korean Med Sci; 2011 Aug; 26(8):991-5. PubMed ID: 21860547
    [TBL] [Abstract][Full Text] [Related]  

  • 26. X-ray repair cross-complementing group 1 Arg399Gln gene polymorphism and susceptibility to colorectal cancer:a meta-analysis.
    Zeng FR; Ling Y; Yang J; Tian XC; Yang X; Luo RC
    Tumour Biol; 2013 Feb; 34(1):555-63. PubMed ID: 23188703
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Association Between the XRCC1 Arg399Gln Polymorphism and the Risk of Head and Neck Cancer: An Updated Meta-Analysis Including 14586 Subjects.
    Xia S; Wu S; Wang M
    Technol Cancer Res Treat; 2021; 20():15330338211033060. PubMed ID: 34278875
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Polymorphisms of DNA repair gene XRCC1 and hepatocellular carcinoma risk among East Asians: a meta-analysis.
    Li J; Li Z; Feng L; Guo W; Zhang S
    Tumour Biol; 2013 Feb; 34(1):261-9. PubMed ID: 23055199
    [TBL] [Abstract][Full Text] [Related]  

  • 29. XRCC1 Arg194TRp and Arg399Gln Polymorphisms and Risk of Non-Hodgkin Lymphoma in a Romanian Population.
    Bogliş A; Radu CG; Tripon F; Crauciuc AG; Demian S; Duicu C; Bănescu C
    Rev Med Chir Soc Med Nat Iasi; 2016; 120(3):644-50. PubMed ID: 30148297
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Arg399Gln substitution in XRCC1 as a prognostic and predictive biomarker for prostate cancer: Evidence from 8662 subjects and a structural analysis.
    Noureddini M; Mobasseri N; Karimian M; Behjati M; Nikzad H
    J Gene Med; 2018 Oct; 20(10-11):e3053. PubMed ID: 30160806
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of XRCC1 gene polymorphisms and pancreatic cancer risk in a Chinese population.
    Wang LJ; Wang HT; Wang XX
    Genet Mol Res; 2016 Jun; 15(2):. PubMed ID: 27323136
    [TBL] [Abstract][Full Text] [Related]  

  • 32. XRCC1 Arg399Gln and Arg194Trp polymorphisms in childhood acute lymphoblastic leukemia risk: a meta-analysis.
    Wang R; Hu X; Zhou Y; Feng Q; Su L; Long J; Wei B
    Leuk Lymphoma; 2013 Jan; 54(1):153-9. PubMed ID: 22712837
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Associations between three XRCC1 polymorphisms and glioma risk: a meta-analysis.
    Zhang H; Liu H; Knauss JL
    Tumour Biol; 2013 Oct; 34(5):3003-13. PubMed ID: 23712607
    [TBL] [Abstract][Full Text] [Related]  

  • 34. XRCC1 Arg399Gln variation and leukemia susceptibility: evidence from 2,647 cases and 5,518 controls.
    Huang Y; Xie D; Tang N; Wang J; Zeng X; Zhao P; He L
    Tumour Biol; 2014 Jan; 35(1):799-808. PubMed ID: 23990457
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quantitative assessment of the association between XRCC1 Arg399Gln and Arg194Trp polymorphisms and risk of cutaneous melanoma.
    Jiang H; Xu W; Zhang F; Wei L; Wang Y; Wang Y; Liu C
    Melanoma Res; 2016 Jun; 26(3):290-9. PubMed ID: 26967970
    [TBL] [Abstract][Full Text] [Related]  

  • 36. No association between the Arg194Trp and Arg399Gln polymorphisms of the XRCC1 gene and colorectal cancer risk and progression in a Polish population.
    Sliwinski T; Krupa R; Wisniewska-Jarosinska M; Lech J; Morawiec Z; Chojnacki J; Blasiak J
    Exp Oncol; 2008 Sep; 30(3):253-4. PubMed ID: 18806752
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Three polymorphisms of DNA repair gene XRCC1 and the risk of glioma: a case-control study in northwest China.
    Xu G; Wang M; Xie W; Bai X
    Tumour Biol; 2014 Feb; 35(2):1389-95. PubMed ID: 24048757
    [TBL] [Abstract][Full Text] [Related]  

  • 38. XRCC1 Arg399Gln polymorphism and risk for cervical cancer development in Argentine women.
    Barbisan G; Pérez LO; Difranza L; Fernández CJ; Ciancio NE; Golijow CD
    Eur J Gynaecol Oncol; 2011; 32(3):274-9. PubMed ID: 21797115
    [TBL] [Abstract][Full Text] [Related]  

  • 39. DNA repair genes polymorphism and lung cancer risk with the emphasis to sex differences.
    Letkova L; Matakova T; Musak L; Sarlinova M; Krutakova M; Slovakova P; Kavcova E; Jakusova V; Janickova M; Drgova A; Berzinec P; Halasova E
    Mol Biol Rep; 2013 Sep; 40(9):5261-73. PubMed ID: 23673479
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association Between Functional Polymorphisms of DNA Double-Strand Breaks in Repair Genes XRCC5, XRCC6 and XRCC7 with the Risk of Systemic Lupus Erythematosus in South East Iran.
    Jahantigh D; Salimi S; Mousavi M; Moossavi M; Mohammadoo-Khorasani M; Narooei-nejad M; Sandoughi M
    DNA Cell Biol; 2015 May; 34(5):360-6. PubMed ID: 25756210
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.